Skip to main content
GM

Gamal M. Ghoniem

🏥 UC Irvine, Orange, CA

Biography​

Gamal M. Ghoniem is emeritus professor of urology at the UCI Health School of Medicine.12 He attended Alexandria Medical School and completed urology residencies at Alexandria University Hospitals and the University of Michigan Medical Center.2 He completed a fellowship in neurourology and female urology at Brown University.2 He previously chaired the International Urogynecological Association's Research and Development Committee.2

Contributions​

His cited work on Macroplastique for female stress urinary incontinence includes a randomized comparison, follow-up studies, and a systematic review and meta-analysis.3456

Cited on WARWIKI

8 publications with Gamal M. Ghoniem as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Maljaars LP, Corcos J, Ghoniem G, et al. Consensus statements on the definition of surgical success following obstetric urinary pelvic floor fistula repair: an IUGA-ICS proposal. Int Urogynecol J. 2026;37:1193–1205. doi
  2. Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of Urethral Bulking Agent Injection for Female Stress Urinary Incontinence: 2-Year Multicenter Study Results. The Journal of Urology. 2010;183(4):1444-1449. doi
  3. Ghoniem G, Corcos J, Comiter C, et al. Cross-Linked Polydimethylsiloxane Injection for Female Stress Urinary Incontinence: Results of a Multicenter, Randomized, Controlled, Single-Blind Study. The Journal of Urology. 2009;181(1):204-210. doi
  4. Ghoniem G, Lane F, Farhan B, et al. Five-Year Follow-Up Study on Safety and Efficacy of Macroplastique® in Female Patients With Stress Urinary Incontinence (The ROSE Study). International Urogynecology Journal. 2025. doi
  5. Hammad MAM, Quesada SG, Belczyk AL, Ghoniem GM. Beyond glycemic control: concurrent GLP-1 receptor agonist use is associated with reduced urinary adverse events following onabotulinumtoxinA treatment in non-diabetic adults with overactive bladder. Toxins. 2025;17(11):542. doi
  6. Ghoniem GM, Miller CJ. A Systematic Review and Meta-Analysis of Macroplastique for Treating Female Stress Urinary Incontinence. International Urogynecology Journal. 2013;24(1):27-36. doi
  7. Langford CF, Udvari Nagy S, Ghoniem GM. Levator ani trigger point injections: an underutilized treatment for chronic pelvic pain. Neurourol Urodyn. 2007;26(1):59-62. doi
  8. Ghoniem GM, Van Leeuwen JS, Elser DM, et al. "A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence." J Urol. 2005;173(5):1647–1653. doi

Footnotes​

  1. Gamal M. Ghoniem, MD. Orange County, CA. Accessed October 2026. ↩

  2. Gamal Ghoniem, MD, FACS, ABU/URPS. Urinary Incontinence & Pelvic Organ Prolapse T. Accessed October 2026. ↩ ↩2 ↩3 ↩4

  3. Ghoniem G, Corcos J, Comiter C, et al. Cross-Linked Polydimethylsiloxane Injection for Female Stress Urinary Incontinence: Results of a Multicenter, Randomized, Controlled, Single-Blind Study. The Journal of Urology. 2009;181(1):204-210. doi:10.1016/j.juro.2008.09.032 ↩

  4. Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of Urethral Bulking Agent Injection for Female Stress Urinary Incontinence: 2-Year Multicenter Study Results. The Journal of Urology. 2010;183(4):1444-1449. doi:10.1016/j.juro.2009.12.038 ↩

  5. Ghoniem G, Lane F, Farhan B, et al. Five-Year Follow-Up Study on Safety and Efficacy of Macroplastique® in Female Patients With Stress Urinary Incontinence (The ROSE Study). International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06163-5 ↩

  6. Ghoniem GM, Miller CJ. A Systematic Review and Meta-Analysis of Macroplastique for Treating Female Stress Urinary Incontinence. International Urogynecology Journal. 2013;24(1):27-36. doi:10.1007/s00192-012-1825-9 ↩